Ions, genes and insulin release: From basic science to clinical disease

Diabetic Medicine

Volumn 17, Issue 2, 2000, Pages 91-104

  Dunne, Mark J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Diazoxide; Hyperinsulinism; Insulin secretion; K(ATP) channels; Neonatal hypoglycaemia; Sulphonylurea

Indexed keywords

CALCIUM CHANNEL; ION CHANNEL; POTASSIUM CHANNEL;

CALCIUM SIGNALING; CONFERENCE PAPER; HORMONAL REGULATION; HYPERINSULINISM; INSULIN RELEASE; MOLECULAR GENETICS; PANCREAS ISLET BETA CELL; REGULATORY MECHANISM;

ANIMALS; CALCIUM; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INFANT, NEWBORN; INSULIN; ISLETS OF LANGERHANS; POTASSIUM CHANNELS;

EID: 0034097830     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00247.x     Document Type: Conference Paper

References (113)

1. 1 Dean PM, Matthews EK. Electrical activity in pancreatic islet cells. Nature 1968; 219: 389-390.
2. 2 Dean PM, Matthews EK. Glucose-induced electrical activity in pancreatic islet cells. J Physiol 1970; 210: 255-264.
3. 3 Matthews EK, Sakamoto Y. Electrical characteristics of pancreatic islet cells. J Physiol 1975; 246: 421-437.
4. 4 Henquin JC, Meissner HP. Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic β-cells. Experientia 1984; 40: 1043-1052.
5. 5 Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981; 391: 85-100.
6. + channels in pancreatic B-cells. Nature 1984; 311: 271-273.
7. 7 Ashcroft FM, Harrison DE, Ashcroft SJH. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature 1984; 312: 446-448.
8. + channels in rat pancreatic β-cells is modulated by ADP. FEBS Lett 1986; 208: 63-66.
9. + channels that are inhibited by ATP in an insulin-secreting cell line. FEBS Lett 1986; 208: 59-62.
10. 2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic β-cells. EMBO J 1995; 14: 50-57.
11. 11 Sturgess NC, Ashford ML, Cook DL, Hales CN. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985; 2: 474-475.
12. 12 Dunne MJ, Petersen OH. Potassium selective ion channels in insulin-secreting cells; physiology, pharmacology and their role in stimulus secretion coupling. Biochimica Biophysica Acta (Rev Biomembranes) 1991; 1071: 67-82.
13. 13 Wollheim CB, Sharp GWG. Regulation of insulin release by calcium. Phys Rev 1981; 61: 914-973.
14. 2+ influx in the electrically excitable pancreatic β-cell. J Biol Chem 1999; 274: 20197-20205.
15. 2+ stores and arachidonic acid metabolism. J Clin Invest 1998; 101: 1623-1632.
16. 2+ in impaired insulin release from islets of diabetic (C57BL/ KsJ-db/db) mice. Am J Physiol 1980; 239: E132-138.
17. 17 Kato S, Ishida H, Tsuura Y, Okamoto Y, Tsuji K, Horie M, Okada Y et al. Increased calcium-channel currents of pancreatic beta cells in neonatally streptozocin-induced diabetic rats. Metabolism 1994; 43: 1395-1400.
18. 2+ channel activity. Am J Physiol 1996; 270: E133-140.
19. 2+ sequestration in diabetic mouse islets of Langerhans. J Biol Chem 1994; 269: 18279-18282.
20. 2+ channel activities in pancreatic β-cells of non-insulin-dependent diabetes mellitus GK rats. J Clin Invest 1996; 97: 2417-2425.
21. 21 Lindstrom P, Sehlin J, Frankel BJ. Glucose-stimulated elevation of cytoplasmic calcium is defective in the diabetic Chinese hamster islet β cell. Eur J Endocrinol 1996; 134: 617-625.
22. 22 January CR, Ribar TJ, Means AR, Augustine GJ. Alterations in calcium channel currents underlie defective insulin secretion in a transgenic mouse. J Biol Chem 1996; 271: 15478-15485.
23. 23 Abdel-Halim SM, Guenifi A, Khan A, Larsson O, Berggren PO, Ostenson G et al. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes 1996; 45: 934-940.
24. 2+ response to glucose in diabetic GK rat. Biochem Biophys Res Commun 1997; 239: 129-133.
25. 25 Hughes SJ, Faehling M, Thorneley CW, Proks P, Ashcroft FM, Smith PA. Electrophysiological and metabolic characterization of single β-cells and islets from diabetic GK rats. Diabetes 1998; 47: 73-81.
26. ATP channel. Proc Natl Acad Sci USA 1997; 94: 11969-11973.
27. ATP deficient mice. Proc Natl Acad Sci USA 1998; 95: 10402-10406.
28. 28 Kindmark H, Kohler M, Arkhammar P, Efendic S, Larsson O, Linder S et al. Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance. Diabetologia 1994; 37: 1121-1131.
29. 2+ channels exposed to serum from patients with type I diabetes. Science 1993; 261: 86-90.
30. 30 Cosgrove KE, Chapman JC, Shepherd RM, McIntyre S, Kjems L, Butler PC et al. Ionic defects in the control of insulin release from human NIDDM β-cells in vitro. Diabetologia 1999; 42 (Suppl. 1): A65.
31. 31 Levy J. Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease. Endocrine 1999; 10: 1-6.
32. 32 Sjoholm A. Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets. Endocrine 1998; 9: 1-13.
33. ATP channels in pancreatic β-cells causes persistent hyperinsulinaemic hypoglycaemia of infancy. Nature Med 1996; 2: 1344-1347.
34. 34 Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, Johnson PR et al. Familial persistent hyperinsulinaemic hypoglycaemia of infancy and mutations in the sulphonylurea receptor. New Eng J Med 1997; 336: 703-706.
35. 35 Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999; 259: 3-17.
36. 36 Aizawa T, Komatsu M, Asanuma N, Sato Y, Sharp GWG. Glucose action 'beyond ionic events' in the pancreatic β-cell. Trends Pharmacol Science 1998; 19: 496-499.
37. 37 Komatsu M, Aizawa T, Yokokawa N, Sato Y, Takasu N, Yamada T. Mastoparan-induced hormone release from rat pancreatic islets. Endocrinology 1992; 30: 221-228.
38. + channels in mouse β cells. J Clin Invest 1992; 89: 1288-1295.
39. +) permeability. Biochem Pharmacol 1992; 43: 2483-285.
40. ATP channel-independent signalling pathways in human islets. Diabetes 1998; 47: 758-764.
41. 41 Straub SG, James RFL, Dunne MJ, Sharp GWG. Glucose augmentation of mastoparan-stimulated insulin secretion in rat and human pancreatic islets. Diabetes 1998; 47: 1053-1057.
42. + channel-independent pathway of glucose signalling in rat pancreatic islets. Diabetes 1999; 48: 1006-1012.
43. 43 Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci USA 1993; 90: 3865-3869.
44. 44 Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor I is required for pancreas development in mice. Nature 1994; 371: 606-609.
45. 45 Froguel P, Velho G. Molecular genetics of maturity-onset diabetes of the young. Trends Eudocrinol Metabolism 1999; 10: 142-146.
46. + channels. Trends Neuroscience 1998; 21: 288-294.
47. ATP channels. Physiol Rev 1998; 78: 227-245.
48. 48 Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE, Gonzalez G et al. Cloning of the β-cell high-affinity sulphonylurea receptor: a regulator of insulin secretion. Science 1995; 268: 423-426.
49. ATP. an inward rectifier subunit plus the sulphonylurea receptor. Science 1995; 270: 1166-1170.
50. 50 Tusnady GE, Bakos E, Varadi A, Sarkadi B. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett 1997; 402: 1-3.
51. + channels. Neuron 1995; 16: 1011-1017.
52. 52 Sakura H, Ämmälä C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 1995; 377: 338-344.
53. ATP channel subunits. Neuron 1997; 18: 827-838.
54. ATP channel complex. J Gen Physiol 1997; 110: 655-664.
55. + channels. Endocrine Rev 1999; 20: 101-135.
56. ATP channels. J Biol Chem 1999; 274: 20628-20632.
57. ATP channels. Neuron 1999; 22: 537-548.
58. ATP channel: separate role of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 1999; 18: 4722-4732.
59. ATP channel. Diabetes 1999; 48: 1341-1347.
60. 60 Uhde I, Toman A, Gross I, Schwanstecher C, Schwanstecher M. Identification of the potassium channel opener site on sulfonylurea receptors. J Biol Chem 1999; 274: 28079-28082.
61. 61 Ashcroft FM, Ashcroft SJH. The sulphonylurea receptor. Biochimica Biophysica Acta 1992; 1175: 45-59.
62. ATP channels. Diabetes 1999; 45: 1439-1445.
63. ATP channels is mediated by Kir 6.2. Proc Natl Acad Sci USA 1998; 94: 11716-11720.
64. 64 Lawson K. Potassium channel activation: a potential therapeutic approach? Pharmacol Therap 1996; 70: 39-63.
65. + channels and inhibition of insulin release; effect of BPDZ-62. J Pharmacol Exp Therapeutics 1996; 277: 156-162.
66. 66 Dunne MJ. Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol 1990; 99: 487-492.
67. 67 Dorschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 1999; 55: 1060-1066.
68. 68 Thomas PM, Cote GJ, Wohllk N, Haddad B, Matthew PM, Rabl W et al. Mutations of the sulphonylurea receptor gene in familial persistent hyperinsulinemic hypoglycaemia of infancy. Science 1995; 268: 426-429.
69. 69 Glaser B, Landau H, Permutt MA. Neonatal hyperinsulinism. Trends Endocrinol Metabolism 1999; 10: 55-61.
70. 70 Glaser B, Thornton PS, Otonkoski T, Junien C. The genetics of neonatal hyperinsulinism. Arch Dis Child 2000; in press.
71. 71 Aynsley-Green A, Polak JM, Bloom SR, Gough MH, Keeling J, Ashcroft SJH et al. Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child 1981; 56: 496-508.
72. 72 Kane C, Lindley KJ, Johnson PRV, James RFL, Milla PJ, Aynsley-Green A et al. Therapy for persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI); understanding the responsiveness of β-cells to diazoxide and somatostatin. J Clin Invest 1997; 100: 1888-1893.
73. 73 Lindley KJ, Dunne MJ, Kane C, Shepherd RM, Squires PE, James RFL et al. Ionic control of β-cells function in nesidioblastosis. A possible therapeutic role for calcium channel blockade? Arch Dis Child 1996; 74: 373-378.
74. 74 Dunne MJ, Cosgrove KE, Shepherd RM, Ämmälä C. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol Metabolism 1999; 10: 146-153.
75. 75 Shyng SL, Ferrigni T, Shepard JB, Nestorowicz A, Glaser B, Permutt MA et al. Functional analyses of novel mutations in the sulphonylurea receptor 1 associated with persistent hyperinsulinaemic hypoglycaemia of infancy. Diabetes, 1998; 47: 1145-1151.
76. 76 Nestorowicz A, Glaser B, Wilson BA, Shyng S-L, Nichols CG, Stanley CA et al. Genetic heterogeneity in familial hyperinsulinism. Human Mol Genetics 1998; 7: 1119-1128.
77. 77 Hupio H, Komulainen J, Rissanen J, Lenko H-L, Laakso M, Otonkoski T. A novel point mutation in sulfonylurea receptor 1 gene associates to diazoxide-responsive form of congenital hyperinsulinism. Hormone Res 1997; 55: 15P.
78. 78 Meissner T, Brune W, Mayatepek E. Persistent hyperinsulinaemic hypoglycemia of infancy: therapy, clinical outcome and mutational analysis. Eur J Paediatrics 1997; 156: 754-757.
79. 79 Ryan F, Devaney D, Joyce C, Nestorowicz A, Permutt MA, Glaser B et al. Hyperinsulinism: molecular aetiology of focal disease. Arch Dis Child 1998; 79: 445-447.
80. 80 Verkarre V, de Fournet JC, Lonlay P, Gross-Morand MS, Devillers M, Rahier J et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998; 102: 1286-1291.
81. 81 De Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C et al. Clinical features of 52 neonates with hyperinsulinism. New Eng J Med 1999; 340: 1169-1175.
82. 82 Swift SM, London, NJM, James RFL. Isolation of human islets and β-cells for pharmacological studies. Diabetes Obesity Metabol 1999; 1: 1-19.
83. 83 Otonkoski T, Ämmälä C, Huopio H, Cote GJ, Chapman JC, Cosgrove KE et al. A point mutation inactivating the sulfonylurea receptor causes the severe form of Persistent Hyperinsulinemic Hypoglycaemia of Infancy in Finland. Diabetes 1999; 48: 408-415.
84. + conductance in glucose-stimulated pancreatic β-cells. Nature 1991; 353: 849-852.
85. 85 Eichmann D, Hufnagel M, Quick P, Santer R. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Paediatrics 1999; 158: 204-206.
86. 86 Cosgrove KE, Shepherd RM, Hashmi MN, Lindley KJ, Aynsley-Green A, Ämmälä C et al. The role of calcium ions in determining insulin hypersecretion in patients with Persistent Hyperinsulinaemic Hypoglycaemia of Infancy (PHHI). Hormone Res 1999; 55: 15P.
87. 2+], oscillations in transgenically derived β-cells. J Biol Chem 1998; 273: 10402-10410.
88. 2+-sensitive non-selective cation channels in regulating the membrane potential of pancreatic β-cells. Diabetes 1998; 47: 1066-1073.
89. ATP channel function. J Physiol 1998; 509: 189P.
90. + channel in insulin-secreting pancreatic β-cells. J Mol Endocrinol 1999; 22: 113-23.
91. 91 Glaser B, Ryan F, Donath M, Landau H, Stanley CA, Baker L et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes 1999; 48: 1652-1657.
92. 92 Patel YC, Srikant CB. Somatostatin receptors. Trends Endocrinol Metabolism 1997; 8: 398-405.
93. ATP channel deficient SUR1-mice. Diabetes 1999; 48: 51,A34.
94. 94 Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A et al. Familial hyperinsulinism caused by an activating glucokinase mutation. New Eng J Med 1998; 338: 226-230.
95. 95 Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. New Eng J Med 1998; 338: 1352-1357.
96. 96 Service FJ, Natt N, Thompson GB, van Heerden JA, Andrews JC, Lorenz E et al. Non-insulinoma pancreatogenous hypoglycaemia: a novel syndrome of hyperinsulinemic hypoglycaemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 1999; 84: 1582-1589.
97. 97 Yorifuji T, Muroi J, Uematsu A, Hiramatsu H, Momoi T. Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics. Hum Genet 1999; 104: 476-479.
98. 98 Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996; 45: 825-831.
99. 99 Hani E, Clement K, Velho G, Vionnet N, Hager J, Phillippi A et al. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes 1997; 46: 688-694.
100. 100 Hansen T, Echwald SM, Hansen L, Moller AM, Almind K, Clausen JO et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 1998; 47: 598-605.
101. + channel and linkage studies with NIDDM in Japanese. Diabetes 1996; 45: 267-269.
102. 102 't Hart LM, de Knijff P, Dekker JM, Stolk RP, Nijpels G, van der Does FEE et al. Varients in the sulphonylurea receptor gene; association of the exon 16-3 t variant with Type II diabetes mellitus in Dutch Caucasians. Diabetologia 1999; 42: 617-621.
103. 103 Elbein SC, Bragg KL, Hoffman MD, Mayorga RA, Leppert MF. Linkage studies of NIDDM with 23 chromosome 11 markers in a sample of whites of northern European descent. Diabetes 1996; 45: 370-375.
104. + channel Kir6.2 (Bir) gene - Identification and lack of role in Caucasian patients with NIDDM. Diabetes 1997; 46: 502-507.
105. + channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998; 41: 1511-1515.
106. 106 Van den Ouweland JM, Maechler P, Wollheim CB, Attardi G, Maassen JA. Functional and morphological abnormalities of mitochondria harbouring the tRNA (Leu) (UUR) mutation in mitochondrial DNA derived from patients with maternally inherited diabetes and deafness (MIDD) and progressive kidney disease. Diabetologia 1999; 42: 485-492.
107. 107 Wang H, Maechler P, Hagenfeldt KA, Wollheim CB. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. EMBO J 1998; 17: 6701-6713.
108. 108 Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou YP, Ostrega D et al. Defective pancreatic β-cell glycolytic signalling in hepatocyte nuclear factor-1alpha-deficient mice. J Biol Chem 1998; 273: 24457-24464.
109. 109 Williams BA, Smith PA, Leow K, Shimizu S, Gray DW, Ashcroft FM. Two types of potassium channel regulated by ATP in pancreatic β-cells isolated from a type-2 diabetic human. Pflugers Arch (Eur J Physiol) 1993; 423: 265-273.
110. 110 MacFarlane WM, Chapman JC, Shepherd RM, Hashmi MN, Kamimura N, Cosgrove KE et al. Engineering a glucose-responsive human insulin-secreting cell line from Islets of Langerhans isolated from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI). J Biol Chem 1999; 274: 34059-34066.
111. 111 MacFarlane WM, Cragg H, Docherty HM, Read ML, James RFL, Aynsley-Green A et al. Impaired expression of transcription factor 1UF1 in a cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). FEBS Lett 1997; 413: 304-308.
112. 112 Aynsley-Green A, Dunne MJ, James Lindley KJ. Ions and genes in persistent hyperinsulinaemic hypoglycaemia of infancy; a commentary on the implications for tailoring treatment to disease pathogenesis. J Paed Endocrinol 1998; 11: 121-129.
113. 113 Aynsley-Green A, Hussein K, Hall JL, Saudubray JM, Fekete C, Otonkoshi T et al. The practical management of hyperinsulinism in infancy. Arch Dis Child 2000; in press.